CRISPR-Scanning Towards New Drugs -- drug discovery is difficult, but CRISPR might be able to help
by Michael Vinyard
figures by Nicholas Lue
Most therapeutic drug candidates that are put through clinical trials fail. Given that most of these fail during early development, the cost of bringing a single drug to market is now over $2.5 billion. If we…